Filters
Other countries
GeneThis summary box displays a gene, condition, or laboratory matching your search query. | BUB1B-BUB1 mitotic checkpoint serine/threonine kinase B |
| Also know as: BUB1beta, BUBR1, Bub1A, MAD3L, MVA1, SSK1, hBUBR1; GeneID:701; Location:15q15.1; | |
| Associated conditions: Colorectal cancer; Mosaic variegated aneuploidy syndrome 1; Premature chromatid separation trait |
Labs matching your search
27 labs with tests matching your search, 2 labs matching in other ways
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods | |
|---|---|---|---|---|
| 2 | 647 |
| ||
| 58 | 43 |
| ||
| 40 | 39 |
| ||
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) | 109 | 99 |
| |
| 1 | 9 |
| ||
| 1 | 86 |
| ||
| 2 | 647 |
| ||
Multigene panel for epilepsies based on whole-exome sequencing | 1 | 646 |
| |
| 1654 | 1199 |
| ||
| 73 | 505 |
| ||
Colorectal cancer, somatic, 114500 (BUB1B gene) (Sequence Analysis-All Coding Exons) (Postnatal) | 1 | 1 |
| |
| 1 | 1 |
| ||
| 1 | 1 |
| ||
| 3 | 1969 |
| ||
| 1 | 52 |
| ||
Ataxia/Episodic Ataxia Disorders (NGS Panel and Copy Number Analysis + mtDNA) | 1 | 536 |
| |
Comprehensive Neuropathies (NGS Panel and Copy Number Analysis + mtDNA) | 1 | 869 |
| |
Comprehensive Muscular Dystrophy/Myopathy (NGS Panel and Copy Number Analysis + mtDNA) | 1 | 911 |
| |
| 1 | 1651 |
| ||
| 1 | 205 |
|
2 conditions, 647 genes
58 conditions, 43 genes
40 conditions, 39 genes
109 conditions, 99 genes
1 condition, 9 genes
1 condition, 86 genes
2 conditions, 647 genes
1 condition, 646 genes
1654 conditions, 1199 genes
73 conditions, 505 genes
1 condition, 1 gene
1 condition, 1 gene
1 condition, 1 gene
3 conditions, 1969 genes
1 condition, 52 genes
1 condition, 536 genes
1 condition, 869 genes
1 condition, 911 genes
1 condition, 1651 genes
1 condition, 205 genes
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.